CRL Stock Analysis: Buy, Sell, or Hold?
CRL - Charles River Laboratories International, Inc.
$232.51
-2.11 (-0.90%)
▼
5d:
+2.62%
30d:
+1.49%
90d:
+39.25%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 05, 2026
2d
Get Alerted When CRL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CRL shows positive signals but monitor for confirmation. Market pricing in 5.7% growth. Moderate conviction.
💡 BUY OPPORTUNITY: CRL shows positive signals but monitor for confirmation. Market pricing in 5.7% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$282.85
Based on 7.5% avg growth
INTRINSIC VALUE TODAY
$175.63
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CRL is currently trading at $232.51, which is considered slightly high relative to its 30-day fair value range of $218.75 to $234.35. From a valuation perspective, the stock is trading at a premium (Forward PE: 18.9) compared to its historical average (16.0). At these levels, the market is pricing in 5.7% annual earnings growth.
Technical Outlook: Technically, CRL is in a strong uptrend. Immediate support is located at $213.40, while resistance sits at $242.73.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CRL is in a strong uptrend. Immediate support is located at $213.40, while resistance sits at $242.73.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$218.75 -
$234.35
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.8%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($228.50)
- BULLISH: Expecting earnings turnaround to 5.7% growth with 1.2% revenue growth
Trading Range Analysis
30-Day Trading Range
$218.75 -
$234.35
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$213.40
Resistance Level
$242.73
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.86
Wall Street Target
$228.50
(-1.7%)
Revenue Growth (YoY)
1.2%
Earnings Growth (YoY)
-17.3%
Profit Margin
-4.6%
Valuation Premium vs History
+5.7% premium
PE vs Historical
18.9 vs 16.0
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.7%
(market-implied from PE analysis)
1-Year Target
$245.76
(+6%)
2-Year Target
$259.77
(+12%)
3-Year Target
$274.58
(+18%)
3-Yr Target (if PE normalizes)
(PE: 19→16)
PE COMPRESSION
$232.98
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 11.0%)
$349.78
(+50%)
Base:
(SPY PE: 18.9, Growth: 11.0%)
$318.18
(+37%)
Bear:
(PE: 16.0, Growth: 11.0%)
$269.97
(+16%)
Share & Embed Analysis
Last updated: August 02, 2026 12:45 PM ET
Data refreshes hourly during market hours. Next update: 1:45 PM
Data refreshes hourly during market hours. Next update: 1:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRL showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
NEUTRAL
Recent Transactions
Ro Khanna
BUY
2026-03-30
Ro Khanna
SELL
2026-02-05
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$630 | 53 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$188 | 61 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$283 | 59 HOLD |
